Abstract
(1,3)-β-D-Glucan (BG) is a component of the Pneumocystis jiroveci cell wall. Thirty-one immunocompromised patients with pneumonia (16 with presumptive pneumocystis pneumonia [PCP] and 15 with non-PCP) were evaluated for serum BG levels. Serum from all 16 presumptive PCP patients and from 2/15 patients with non-PCP was positive for BG. Results indicate that BG is a reliable marker for diagnosing PCP.
| Original language | English |
|---|---|
| Pages (from-to) | 1524-1526 |
| Number of pages | 3 |
| Journal | Clinical and Vaccine Immunology |
| Volume | 16 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Oct 2009 |
Fingerprint
ASJC Scopus subject areas
- Clinical Biochemistry
- Immunology
- Immunology and Allergy
- Microbiology (medical)
Cite this
Clinical evaluation of a (1,3)-β-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients. / Del Bono, Valerio; Mularoni, Alessandra; Furfaro, Elisa; Delfino, Emanuele; Rosasco, Lorenzo; Miletich, Franca; Viscoli, Claudio.
In: Clinical and Vaccine Immunology, Vol. 16, No. 10, 10.2009, p. 1524-1526.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Clinical evaluation of a (1,3)-β-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients
AU - Del Bono, Valerio
AU - Mularoni, Alessandra
AU - Furfaro, Elisa
AU - Delfino, Emanuele
AU - Rosasco, Lorenzo
AU - Miletich, Franca
AU - Viscoli, Claudio
PY - 2009/10
Y1 - 2009/10
N2 - (1,3)-β-D-Glucan (BG) is a component of the Pneumocystis jiroveci cell wall. Thirty-one immunocompromised patients with pneumonia (16 with presumptive pneumocystis pneumonia [PCP] and 15 with non-PCP) were evaluated for serum BG levels. Serum from all 16 presumptive PCP patients and from 2/15 patients with non-PCP was positive for BG. Results indicate that BG is a reliable marker for diagnosing PCP.
AB - (1,3)-β-D-Glucan (BG) is a component of the Pneumocystis jiroveci cell wall. Thirty-one immunocompromised patients with pneumonia (16 with presumptive pneumocystis pneumonia [PCP] and 15 with non-PCP) were evaluated for serum BG levels. Serum from all 16 presumptive PCP patients and from 2/15 patients with non-PCP was positive for BG. Results indicate that BG is a reliable marker for diagnosing PCP.
UR - http://www.scopus.com/inward/record.url?scp=70349696878&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70349696878&partnerID=8YFLogxK
U2 - 10.1128/CVI.00276-09
DO - 10.1128/CVI.00276-09
M3 - Article
VL - 16
SP - 1524
EP - 1526
JO - Clinical and Vaccine Immunology
JF - Clinical and Vaccine Immunology
SN - 1556-6811
IS - 10
ER -